BioSpace News Archive

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that results from FORWARD, a five-year, multicenter Phase II study of sprifermin, a recombinant human fibroblast growth factor-18, in patients with symptomatic radiographic knee osteoarthritis (OA) were published online in the Journal of the American Medical Association (JAMA).

Lab Effects, the longest-running terpene laboratory in the cannabis industry, maintains a zero-tolerance approach to hazardous ingredients found in vape formulas.

Omega Laboratories, Inc. announced that they have secured DENATRAN accreditation for their 1,300+ sq. meter São Paulo facility, Omega Global Laboratory Services Do Brasil.

Foot and ankle patients can now access top physicians from anywhere in the world

Recipients will receive funding to support proposals that demonstrate innovation in awareness and education, self-advocacy and/or policy improvement

New England Peptide, a leading provider of high-quality custom peptides and antibodies to the global life sciences market, announced the majority recapitalization of the company by Ampersand Capital Partners.

SAB Members Bring Cancer Immunotherapy and Clinical Trial Experience to the Development of Bolt’s Immune-stimulating Antibody Conjugate Technology

Montefiore Einstein Doctor Receives NIH Grant to Expand Newborn Screening and Improve Diagnosis and Access to Treatment [08-October-2019] NEW YORK , Oct. 8, 2019 /PRNewswire/ -- Pediatric genetic expert Dr. Melissa Wasserstein has been awarded $3.2 million from the National Institutes of Health (NIH) to conduct the most expansive consented pilot newborn screenin

Partnership Combines Life Image’s Global Medical Evidence Network Specializing in Imaging Data with Graticule’s Deep Expertise Applying Advanced Data to High-Value Use Cases

Company scientists presented the study results at the 2020 Keystone Symposia Conference -- Microbiome: Therapeutic Implications in Killarney, Ireland.